WASHINGTON (AP) -- The Supreme Court agreed Friday to decide how far states can go in negotiating lower prescription costs for the poor, accepting drug companies' challenge of a pioneering Maine law.
The intervention stops, for now, Maine's effort to press companies to drop prices for about 325,000 residents who don't have insurance.
An appeals court had rejected arguments from a drug industry trade group that the Maine program unconstitutionally regulates transactions in other states and conflicts with federal Medicaid law. The high court will review the case next year.
The court's decision to take the Maine case came just hours after the House approved a prescription drug bill targeting the Medicare program, which covers the elderly and disabled.
Brainerd Dispatch ©2013. All Rights Reserved.